Table 1.
Current direct and indirect AMPK activators
Activator | Effect on AMPK | Mechanism |
---|---|---|
Metformin | indirect | Increase AMP/ATP by inhibition of complex 1 of mitochondrial respiratory chain |
TZDs* | indirect | Increase PPARγ-mediated release of adiponectin, which consequently activates AMPK |
Deguelin | indirect | Not fully clarified. Decrease of ATP |
Epigallocatechin-3-gallate | indirect | Activation of the AMPK activator CaMKK** |
Barberin | indirect | Increase AMP/ATP by inhibition of mitochondrial function |
α-Lipoic acid | indirect | n.d. |
Resveratrol | indirect | Not fully clarified. Possible activation of SIRT1*** and consequent deacetylation of the AMPK activator LKB1 |
AICAR **** | direct | AMP mimetic |
A-769662 | direct | Allosteric binding of β1 AMPK subunit |
PT1 | direct | Allosteric binding of α1 AMPK subunit |
n.d.= not determined yet,
TZDs= thazolidinediones,
CAMKK= Calmodulin-dependent protein kinase kinase,
SIRT1= sirtuin 1,
AICAR= 5-Aminoimidazole-4-carboxamide-1-b-riboside.